Agreements and Transactions	3 Months Ended
Mar. 31, 2017
Agreements and Transactions [Abstract]
Agreements and Transactions with Baxter	Agreements and Transactions with Baxter In connection with Baxalta’s separation from Baxter on July 1, 2015, Baxalta and Baxter entered into several separation-related agreements that provided a framework for Baxalta’s relationship with Baxter after the separation. These agreements, among others, included a manufacturing and supply agreement, a transition services agreement and a tax matters agreement. For further details on existing agreements with Baxter, refer to Note 28, Agreements and Transactions with Baxter, of Shire's 2016 Form 10-K. During the three months ended March 31, 2017, the Company reported revenues associated with the manufacturing and supply agreement with Baxter of approximately $40.3 million and Selling, general and administrative expenses associated with the transition services agreement with Baxter of approximately $18.9 million. Net tax-related indemnification liabilities as of March 31, 2017 associated with the tax matters agreement with Baxter are discussed in Note 18, Commitments and Contingencies, of these Unaudited Consolidated Financial Statements. As of March 31, 2017, the Company had total amounts due from or to Baxter of $142.9 million reported in Prepaid expenses and other current assets, $33.6 million reported in Other non-current assets, $65.4 million reported in Other current liabilities and $78.0 million reported in Other non-current liabilities.

Agreements and Transactions with Baxter

In connection with Baxalta’s separation from Baxter on July 1, 2015, Baxalta and Baxter entered into several separation-related agreements that provided a framework for Baxalta’s relationship with Baxter after the separation. These agreements, among others, included a manufacturing and supply agreement, a transition services agreement and a tax matters agreement. For further details on existing agreements with Baxter, refer to Note 28, Agreements and Transactions with Baxter, of Shire's 2016 Form 10-K.

During the three months ended March 31, 2017, the Company reported revenues associated with the manufacturing and supply agreement with Baxter of approximately $40.3 million and Selling, general and administrative expenses associated with the transition services agreement with Baxter of approximately $18.9 million. Net tax-related indemnification liabilities as of March 31, 2017 associated with the tax matters agreement with Baxter are discussed in Note 18, Commitments and Contingencies, of these Unaudited Consolidated Financial Statements.

As of March 31, 2017, the Company had total amounts due from or to Baxter of $142.9 million reported in Prepaid expenses and other current assets, $33.6 million reported in Other non-current assets, $65.4 million reported in Other current liabilities and $78.0 million reported in Other non-current liabilities.